We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+9.53%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$6.09B
AUM Growth
+$393M
(+6.9%)
Cap. Flow
-$95.1M
Cap. Flow
% of AUM
-1.56%
Top 10 Holdings %
Top 10 Hldgs %
33.43%
Holding
956
New
52
Increased
378
Reduced
294
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lazard
LAZ
|
+$10.7M |
| 2 |
QGENF
QIAGEN NV
QGENF
|
+$8.34M |
| 3 |
Cisco
CSCO
|
+$8.11M |
| 4 |
FRC
First Republic Bank
FRC
|
+$7.27M |
| 5 |
Phillips 66
PSX
|
+$6.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deutsche Bank
DB
|
+$39M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$11.6M |
| 3 |
Target
TGT
|
+$10.9M |
| 4 |
GE Aerospace
GE
|
+$10.3M |
| 5 |
PNC Financial Services
PNC
|
+$8.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.83% |
| 2 | Healthcare | 16% |
| 3 | Technology | 10.83% |
| 4 | Communication Services | 9.48% |
| 5 | Industrials | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TGA
601
DELISTED
Transglobe Energy Corp
TGA
| $331K | 0.01% |
+40,000
| New | +$353K |
|
|
ARRY
602
DELISTED
Array Biopharma Inc
ARRY
| $326K | 0.01% |
66,900
+1,500
| +2% | +$8.17K |
|
|
OREX
603
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $323K | 0.01% |
5,650
+350
| +7% | +$19.7K |
|
604
IAMGOLD
IAG
$10.5B
| $321K | 0.01% |
+97,716
| New | +$423K |
|
|
SPPI
605
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $321K | 0.01% |
36,200
+2,500
| +7% | +$22.3K |
|
|
X
606
DELISTED
US Steel
X
| $316K | 0.01% |
+10,413
| New | +$268K |
|
607
IDT Corp
IDT
$1.62B
| $314K | 0.01% |
24,738
-7,781
| -24% | -$110K |
|
|
OSIR
608
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $313K | 0.01% |
18,800
+400
| +2% | +$6.38K |
|
609
General Dynamics
GD
$106B
| $308K | 0.01% |
+3,248
| New | +$290K |
|
610
Cemex
CX
$16.3B
| $307K | 0.01% |
+30,533
| New | +$287K |
|
|
INVX
611
Innovex International
INVX
$1.97B
| $300K | ﹤0.01% |
2,698
| – | – |
|
|
MACK
612
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $299K | ﹤0.01% |
7,372
+572
| +8% | +$16.6K |
|
613
CEMIG Preferred Shares
CIG
$6.01B
| $293K | ﹤0.01% |
98,249
+20,009
| +26% | +$66.3K |
|
614
Itron
ITRI
$4.54B
| $290K | ﹤0.01% |
7,000
| – | – |
|
|
SGYP
615
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $290K | ﹤0.01% |
52,221
+1,014
| +2% | +$4.37K |
|
616
Oceaneering
OII
$4.77B
| $289K | ﹤0.01% |
3,665
-12,377
| -77% | -$1M |
|
617
Sonoco
SON
$5.74B
| $287K | ﹤0.01% |
6,900
| – | – |
|
|
AMAG
618
DELISTED
AMAG Pharmaceuticals
AMAG
| $286K | ﹤0.01% |
12,400
+300
| +2% | +$7.06K |
|
619
First Solar
FSLR
$26.9B
| $276K | ﹤0.01% |
5,000
-87,600
| -95% | -$4.79M |
|
620
Landstar System
LSTR
$6.21B
| $276K | ﹤0.01% |
4,800
| – | – |
|
621
Logitech
LOGI
$15.2B
| $275K | ﹤0.01% |
20,000
| – | – |
|
|
DNDN
622
DELISTED
DENDREON CORPORATION
DNDN
| $275K | ﹤0.01% |
90,000
+2,000
| +2% | +$5.63K |
|
623
Alaska Air
ALK
$5.58B
| $274K | ﹤0.01% |
7,600
-15,600
| -67% | -$554K |
|
|
AVNR
624
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $273K | ﹤0.01% |
82,900
+2,000
| +2% | +$8.26K |
|
625
Delta Air Lines
DAL
$60.1B
| $265K | ﹤0.01% |
9,825
+3,145
| +47% | +$84.5K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q4 2013 Portfolio in Review
As of Q4 2013, DekaBank Deutsche Girozentrale held 956 positions worth $6.09B, up 6.9% from $5.69B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
DekaBank Deutsche Girozentrale's Q4 2013 filing shows 52 new, 378 increased, 294 reduced and 42 closed positions. Its largest new stake was Lazard: 264,565 shares worth $11.9M. The largest sale was Deutsche Bank, an estimated $39M.
By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Technology.
- DekaBank Deutsche Girozentrale's largest Q4 2013 buy was Lazard: 264,565 shares worth $11.9M.
- DekaBank Deutsche Girozentrale added most to QIAGEN NV in Q4 2013, an estimated $8.34M increase.
- DekaBank Deutsche Girozentrale's biggest Q4 2013 reduction was Deutsche Bank, cutting an estimated $39M.
- DekaBank Deutsche Girozentrale fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $5.92M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 33% of its $6.09B portfolio in Q4 2013.
- DekaBank Deutsche Girozentrale opened 52 new positions and closed 42 in Q4 2013.
- DekaBank Deutsche Girozentrale's portfolio value rose 6.9% quarter-over-quarter to $6.09B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2013, filed 11 Feb 2014.